Damora Therapeutics, Inc. · NASDAQ:DMRA
Point72 Asset Management, L.P. reported a 6.30% stake in Damora Therapeutics, Inc. (Schedule 13G)
Event Nov 12, 2025 · Filed Nov 13, 2025
Point72 Asset Management, L.P. reported a 6.30% stake in Damora Therapeutics, Inc., 100,001 shares, as a passive investor on Nov 12, 2025. Filed Nov 13, 2025 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 100,001
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 6.30% | 100,001 |
| Point72 Capital Advisors, Inc. | 6.30% | 100,001 |
| Steven A. Cohen | 6.30% | 100,001 |
Source
Related
- Damora Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Damora Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026